Newcells Biotech Limited

Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the decision-making process in drug development by providing best in class in vitro models that most accurately predict in vivo outcomes. Strong links with global Pharmaceutical and Biotech companies and academic centres of excellence. Newcells builds functionally relevant in vitro models that accurately predict in vivo outcomes. Globally recognised scientific expertise and innovation is embedded in all it’s products and services. Using our expertise in induced pluripotent stem cells (iPSCs), cellular physiology and organoid technology, we engineer models of kidney, retina, liver and lung from patient samples as well as from a range of preclinical species.